Publications by authors named "Ismail Yalcin"

Claim this Profile
I
Insight into Mechanism of Action of Anticancer Benzazoles.
Ozum Ozturk, Esin Aki-Yalcin, Ismail Yalcin, Renate Grifitth

Curr Top Med Chem· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benzoxazines as new human topoisomerase I inhibitors and potential poisons.
Egemen Foto, Çigdem Özen, Fatma Zilifdar, Betül Tekiner-Gülbaş, İlkay Yıldız

Daru· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 12 AFMC International Medicinal Chemistry Symposium (AIMECS 2019) in Istanbul, Turkey.
Abdurrahman Olgac, Ismail Yalcin, Esin Aki-Yalcin

ChemMedChem· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of the Apoptotic Effect and Molecular Docking of Benzamide Derivative XT5 in K562 Cells.
Tulin Ozkan, Yalda Hekmatshoar, Tugba Ertan-Bolelli, Andry N Hidayat, Meral Beksac, Esin Aki-Yalcin, Ismail Yalcin

Anticancer Agents Med Chem· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of 2-substituted-5-(4-trifluoromethylphenyl-sulphonamido)benzoxazole derivatives as human GST P1-1 inhibitors.
Tugba Ertan-Bolelli, Kayhan Bolelli, Yaman Musdal, Ilkay Yildiz, Esin Aki-Yalcin, Ismail Yalcin

Artif Cells Nanomed Biotechnol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological evaluation and pharmacophore modeling of some benzoxazoles and their possible metabolites.
Fatma Zilifdar, Egemen Foto, Tugba Ertan-Bolelli, Esin Aki-Yalcin, Ismail Yalcin

Arch Pharm (Weinheim)· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4-Thiazolidinone Derivatives as MMP Inhibitors in Tissue Damage: Synthesis, Biological Evaluation and Docking Studies.
Matteo Incerti, Lucia Crascì, Paola Vicini, Esin Aki, Ismail Yalcin

Molecules· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of retention characteristics of heterocyclic compounds.
Karel Nesměrák, Andrey A Toropov, Alla P Toropova, Ilkay Yildiz, Ismail Yalcin

Anal Bioanal Chem· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological evaluation of 2-substituted-5-(4-nitrophenylsulfonamido)benzoxazoles as human GST P1-1 inhibitors, and description of the binding site features.
Tuğba Ertan-Bolelli, Yaman Musdal, Kayhan Bolelli, Serap Yilmaz, Yasemin Aksoy, Esin Aki-Yalcin, Ismail Yalcin

ChemMedChem· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, biological evaluation and 2D-QSAR analysis of benzoxazoles as antimicrobial agents.
Tugba Ertan, Ilkay Yildiz, Betul Tekiner-Gulbas, Kayhan Bolelli, Ozlem Temiz-Arpaci, Ismail Yalcin

Eur J Med Chem· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological activity of some new benzoxazoles.
Ozlem Temiz-Arpaci, Ilkay Yildiz, Semiha Ozkan, Fatma Kaynak, Esin Aki-Sener

Eur J Med Chem· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Some benzoxazoles and benzimidazoles as DNA topoisomerase I and II inhibitors.
Emine Oksuzoglu, Betul Tekiner-Gulbas, Sabiha Alper, Ozlem Temiz-Arpaci, Tugba Ertan, Ismail Yalcin

J Enzyme Inhib Med Chem· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological evaluation of new N-(2-hydroxy-4(or 5)-nitro/aminophenyl)benzamides and phenylacetamides as antimicrobial agents.
Tugba Ertan, Ilkay Yildiz, Semiha Ozkan, Ozlem Temiz-Arpaci, Fatma Kaynak, Ismail Yalcin

Bioorg Med Chem· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and ex vivo activity of thioridazine derivatives against Mycobacterium tuberculosis.
Marta Martins, Zsuzsanna Schelz, Ana Martins, Joseph Molnar, Gyorgy Hajös, Ismail Yalcin

Int J Antimicrob Agents· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High antineoplastic activity of new heterocyclic compounds in cancer cells with resistance against classical DNA topoisomerase II-targeting drugs.
Hermann Lage, Esin Aki-Sener, Ismail Yalcin

Int J Cancer· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3D-QSAR analysis on benzazole derivatives as eukaryotic topoisomerase II inhibitors by using comparative molecular field analysis method.
Ozlem Temiz-Arpaci, Betul Tekiner-Gulbas, Ilkay Yildiz, Esin Aki-Sener, Ismail Yalcin

Bioorg Med Chem· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of apoptosis and necrosis by resistance modifiers benzazoles and benzoxazines on tumour cell line mouse lymphoma L5718 Mdr+cells.
Andras Varga, Esin Aki-Sener, Ismail Yalcin, Ozlem Temiz-Arpaci, Betul Tekiner-Gulbas

In Vivo· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and antimicrobial activity of some 5-[2-(morpholin-4-yl)acetamido] and/or 5-[2-(4-substituted piperazin-1-yl)acetamido]-2-(p-substituted phenyl)benzoxazoles.
Ozlem Temiz-Arpaci, Aliye Ozdemir, Ismail Yalçin, Ilkay Yildiz, Esin Aki-Sener

Arch Pharm (Weinheim)· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and antimicrobial activity of new 2-[p-substituted-benzyl]-5-[substituted-carbonylamino]benzoxazoles.
Ilkay Yildiz-Oren, Betul Tekiner-Gulbas, Ismail Yalcin, Ozlem Temiz-Arpaci, Esin Aki-Sener

Arch Pharm (Weinheim)· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A target site for template-based design of measles virus entry inhibitors.
Richard K Plemper, Karl J Erlandson, Ami S Lakdawala, Aiming Sun, Andrew Prussia, Ismail Yalcin

Proc Natl Acad Sci U S A· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Some fused heterocyclic compounds as eukaryotic topoisomerase II inhibitors.
Asli Pinar, Pinar Yurdakul, Ilkay Yildiz, Ozlem Temiz-Arpaci, N Leyla Acan, Ismail Yalcin

Biochem Biophys Res Commun· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and structure-activity relationships of new antimicrobial active multisubstituted benzazole derivatives.
Ilkay Yildiz-Oren, Ismail Yalcin, Esin Aki-Sener, Nejat Ucarturk

Eur J Med Chem· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Some new bi- and ter-benzimidazole derivatives as topoisomerase I inhibitors.
Sabiha Alper, Ozlem Temiz Arpaci, Esin Sener Aki, Ismail Yalçin

Farmaco· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and HIV-1 reverse transcriptase inhibitor activity of some 2,5,6-substituted benzoxazole, benzimidazole, benzothiazole and oxazolo(4,5-b)pyridine derivatives.
Ayşegül Akbay, Ilkay Oren, Ozlem Temiz-Arpaci, Esin Aki-Sener, Ismail Yalçin

Arzneimittelforschung· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and microbiological activity of some novel N-[2-(p-substitutedphenyl)-5-benzoxazolyl]-cyclohexyl carboxamide, -cyclohexyl acetamide and -cyclohexyl propionamide derivatives.
Ozlem Temiz Arpaci, Esin Aki Sener, Ismail Yalçin, Nurten Altanlar

Farmaco· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis